Home › Cancer (all types) › NCT02970045

Norris ORIEN Total Cancer Care

Norris ORIEN Total Cancer Care Protocol: A Lifetime Partnership With Patients

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Limited to those patients who are registered for outpatient or inpatient care at University of Southern California (USC) Norris
* Able to understand and sign the TCCP informed consent, California subject's bill of rights, Health Insurance Portability and Accountability Act (HIPAA), and research authorization form directly or through an authorized representative; the informed consent, subject's bill of rights, HIPAA, and research authorization will be available in both English and Spanish languages

Exclusion Criteria:

* Individuals who are not registered as patients for outpatient or inpatient care at USC Norris
* Individuals who are unable to understand or sign the TCCP informed consent, subject's bill of rights, HIPAA, and research authorization in either English or Spanish

About the study

This research trial collects biological samples and clinical information to create a repository of data from patients with cancer or a predisposition for cancer. Combining genetic information from biological samples and clinical data may lead to more knowledge about why certain cancers respond to treatment and help create more personalized medicine.

What is being tested

• Biospecimen Collection (procedure)
• Evaluation of Cancer Risk Factors (procedure)
• Medical Chart Review (other)
• Quality-of-Life Assessment (other)
• Questionnaire Administration (other)

Sponsor: University of Southern California · Participants: 10,000 · Started: May 2, 2016

Contact the study team

• Melissa Woodhouse, MHA, MPH · Phone: 323-865-0489

Official record on ClinicalTrials.gov — NCT02970045

Locations in the U.S.

Conditions

• Cancer (all types)

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.